Improving Diabetic Wound-Healing Outcomes With Topical Growth Factor Therapies.

Andrew Yew Wei WongNatalie Ming Foong HooiBrian Sheng Yep YeoRehena SultanaYong Mong BeeAinsley Ryan Yan Bin Lee Sook Muay Tay

Published in: The Journal of clinical endocrinology and metabolism (2024)

HUC, hEGF, and FGF are promising topical biologics with statistically significant primary outcomes compared to SOC, while PRP is effective in reducing ulcer-related AEs. HUC has been found to be the most effective in terms of cure rate and a reduction in time to cure.

Keyphrases

wound healing
growth factor
type diabetes
metabolic syndrome
glycemic control